About Cellex

Cellex provides automated bioreactor systems for advanced cell culture and tissue engineering. Their BioAxFlow bioreactor ensures uniform cell seeding and distribution on scaffolds through a continuous perfusion system, improving cell viability and reproducibility in 3D tissue development.

<problem> Current methods for advanced cell culture and 3D tissue engineering often struggle with achieving uniform cell distribution on scaffolds, which is critical for consistent tissue development. Manual cell seeding processes are labor-intensive and can lead to suboptimal cell viability and distribution, hindering the creation of functional engineered tissues. </problem> <solution> Cellex develops automated bioreactor systems designed to address the challenges of uniform cell seeding and distribution in tissue engineering applications. Their BioAxFlow bioreactor utilizes a continuous perfusion system to gently introduce cell culture medium from the bottom of the vessel, facilitating cell suspension and even distribution onto various scaffold geometries. This automated approach ensures consistent cell seeding, promoting enhanced cell viability and enabling more reproducible 3D cell culture outcomes. The system is engineered for ease of use, supporting researchers in scientific, medical, and pharmaceutical fields to advance their tissue engineering projects. </solution> <features> - Automated cell seeding via a continuous perfusion system for uniform cell distribution on diverse scaffold types. - Integrated vessel design to support 3D cell culture and tissue construct development. - Compatibility with external peristaltic pumps and tubing for controlled media flow. - Designed for ease of operation in advanced cell culture and tissue engineering workflows. - Focus on enhancing cell viability and reproducibility in engineered tissue creation. </features> <target_audience> The primary customers are researchers and developers in scientific, medical, and pharmaceutical sectors engaged in advanced cell culture and tissue engineering. </target_audience>

What does Cellex do?

Where is Cellex located?

Cellex is based in Rome, Italy.

When was Cellex founded?

Cellex was founded in 2018.

Location

Rome, Italy

Founded

2018

Employees

12 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Cellex

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

cellex.it 1K+

Founded 2018 – Rome, Italy

Funding

No funding information available.

Team (10+)

No team information available.

Company Description

Problem

Current methods for advanced cell culture and 3D tissue engineering often struggle with achieving uniform cell distribution on scaffolds, which is critical for consistent tissue development. Manual cell seeding processes are labor-intensive and can lead to suboptimal cell viability and distribution, hindering the creation of functional engineered tissues.

Solution

Cellex develops automated bioreactor systems designed to address the challenges of uniform cell seeding and distribution in tissue engineering applications. Their BioAxFlow bioreactor utilizes a continuous perfusion system to gently introduce cell culture medium from the bottom of the vessel, facilitating cell suspension and even distribution onto various scaffold geometries. This automated approach ensures consistent cell seeding, promoting enhanced cell viability and enabling more reproducible 3D cell culture outcomes. The system is engineered for ease of use, supporting researchers in scientific, medical, and pharmaceutical fields to advance their tissue engineering projects.

Features

Automated cell seeding via a continuous perfusion system for uniform cell distribution on diverse scaffold types.

Integrated vessel design to support 3D cell culture and tissue construct development.

Compatibility with external peristaltic pumps and tubing for controlled media flow.

Designed for ease of operation in advanced cell culture and tissue engineering workflows.

Focus on enhancing cell viability and reproducibility in engineered tissue creation.

Target Audience

The primary customers are researchers and developers in scientific, medical, and pharmaceutical sectors engaged in advanced cell culture and tissue engineering.